Search results
Results from the WOW.Com Content Network
Launch of the Coalition for Epidemic Preparedness Innovations, CEPI in 2017 at the World Economic Forum in Davos, Switzerland. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).
Richard Hatchett is an American oncologist [1] and epidemiologist who has been serving as chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017. [2] [3] He was awarded the Secretary of Health and Human Services's Award for Distinguished Service. [4]
Cepi may refer to: Čepí, a village in the Pardubice Region of the Czech Republic. Coalition for Epidemic Preparedness Innovations, a Norway-based foundation that finances vaccine development; Confederation of European Paper Industries, a pan-European association representing the forest fibre and paper industry; Frank Cepollina, American engineer
In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019. [3] On February 16, 2022, Robinson was awarded a two-year, $340,000 grant by the Arnold Ventures Foundation to study biosimilars to determine potential cost savings from wider use of them. [4]
The ACT Accelerator is a multinational collaboration, and multistakeholder initiative including the World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI), FIND, [4] GAVI the Vaccine Alliance, [5] the Global Fund, UNICEF, Unitaid, Wellcome, the World Bank and governments, to raise financial support of accelerated ...
The Confederation of European Paper Industries (CEPI) is the pan-European association representing the forest fibre and paper industry. Through its 18 national associations, CEPI gathers 495 companies operating more than 900 pulp and paper mills across Europe producing paper, cardboard , pulp and other bio-based products.
Vaccines offer new opportunities for funding from public-private partnerships (such as CEPI [5] [31] and GAVI [32]), governments, and philanthropic donors and foundations (such as GAVI and CEPI's donors [5] [32]). Pharmaceutical companies have representation on the boards of public-private global health funding bodies including GAVI [33] and CEPI.
By November 2020, CEPI had invested $328 million to develop the vaccine. If the vaccine was successful, CEPI's investment would help scale-up production to over 1 billion doses a year. [ 14 ] Previously, CEPI provided $3.5 million to support Phase I trials and later an additional $66 million in July 2020 to expand clinical testing and prepare ...